Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Dec. 15, 2025. Document 2025-22763. Updated Nov. 16, 2026.
- What it does
The Administrator of the Drug Enforcement Administration is issuing this notification of intent to publish a temporary order to schedule 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle bromazolam.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What it would change
1 part of Title 21 of the Code of Federal Regulations:
- What happens next and when
December 15, 2025.
The agency's dates, word for word.
The record as published
| Document number | 2025-22763 |
|---|---|
| Action | Proposed amendment; notification of intent. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | Dec. 15, 2025 |
| Docket | DEA-2025-0885 |
Source: the Federal Register (public domain). The document in the Federal Register